TRKA | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

730 results for “TRKA”

Trials

View all 642 →

NGF, TrKA,p75NTR in Men With ED and Diabetes With or Without MS

40 participants · First posted Mar 5, 2019

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

242 participants · First posted Jun 14, 2018

Transient Receptor Potential Vanilloid One (TRPV1) Receptor Expression in Children With Retrosternal Pain

77 participants · First posted May 14, 2008

Drugs

View all 61 →

TrkA-NAM

TrkA antagonists(Cephalon, Inc)

IRAK4/TrkA (Evommune/Dermira)

Organizations

KRKA dd

Slovenia

KRKA-FARMA d.o.o.

Croatia

KRKA, d.d., Novo mesto

Slovenia

News

View all 24 →

Bedinvetmab Shows Strong Safety Profile in Canine Laboratory Studies

XtalPi Files FDA IND for KQTD-126, a Gut-Restricted pan-TRK Inhibitor for IBS and IBD Pain

Kasvu Therapeutics Raises €30M to Advance Non-Hallucinogenic TrkB-Targeting Depression Drug KTX-0141

Page 1 of 73